Baseline characteristics
ONCOLOGY
Most baseline sociodemographic and clinical characteristics were balanced across groups (Baseline characteristicsImmunotherapy combined: immunotherapy (combined with chemotherapy or chemoradiation and/or surgery and/or targeted therapy. Radiotherapy combined: radiotherapy (combined with surgery). Chemotherapy combined: chemotherapy or chemoradiation (combined with radiotherapy, and/or targeted therapy and/or surgery). ECOG = Eastern Cooperative Oncology Group; M− = no targetable driver mutation or unknown status; M+ = targetable driver mutation.Between the reactive and active intervention groups, exceptions were found in the same baseline characteristics (stage distribution, histology, and treatment). In addition, the reactive group had statistically significantly fewer patients with an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 compared with the active intervention group (52% vs 38%; Patients who did not complete the follow-up questionnaire had a statistically significantly worse ECOG performance status and stage distribution (data not shown). However, no differences were observed between patients in the control vs the intervention group.